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Since  the discovery of scarlet  fever toxin  (Dick and Dick  (1); Dochez (2))  there 
have been numerous attempts to isolate the active substance from the culture filtrates 
of scarlatinal  strains  of hemolytic streptococcus.  Although the erythrogenic toxin 
has been purified to varying degrees, there has been little agreement in the literature 
as to its chemical nature or regarding the extent  of purification attained.  Some of 
the  earlier  workers  suggested  that  the  toxin  might  be  a  nitrogenous carbohydrate 
(Korschun et al.  (3);  Stock  (4)).  Dick and Boor (5)  isolated a  fraction of reduced 
nitrogen content containing 30,000 skin test doses per mg.  The most active prepara- 
tion of scarlet fever toxin that has been reported was that isolated by Stock (6).  His 
purest material contained 11 per cent nitrogen and 10,000,000 skin test doses per mg. 
Stock's purest preparations presumably consist mainly of protein, but little has been 
stated  regarding their  chemical properties.  On the  other hand  Barron,  Dick,  and 
Lyman (7) have recently carried out an extensive chemical study on material contain- 
ing only 30,000 S.T.D.  1 per mg., which, from electrophoresis data, they regard as about 
35 per cent pure.  The latter authors conclude that scarlet fever toxin is a protein of 
low molecular weight and unusual stability.  Finally, Koerber and Bunney (8) have 
described a  "protein-free"  scarlet  fever toxin which they isolated from a  casein hy- 
drolysate medium.  Their preparations contain only 0.7 to 1.0 per cent nitrogen and 
about  100,000  S.T.D. per mg.  For further  references  to work on the purification of 
scarlet fever toxin, the paper by Stock (6) should be consulted. 
In view  of the  contradictory  results  obtained  by other  workers,  we  have 
deemed  it  important  to  find  some  independent  method  for  estimating  the 
activity of pure  scarlet  fever toxin before actually attempting  to isolate  it in 
its  purest  form.  The flocculation reaction  appeared  to offer possibilities  for 
such a method.  In a quantitative study of the Ramon diphtheria flocculation 
reaction, Pappenheimer and Robinson (9) showed that, within the equivalence 
zone, the nitrogen precipitated from a given amount of antitoxin varied linearly 
with the toxin added.  The slope of this straight line was shown to represent 
* The  expenses  of this  work  have  been  defrayed by a  generous grant  from  the 
Commonwealth Fund. 
The abbreviation S.T.D. for skin test doses will be used throughout the rest of this 
paper. 
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the  nitrogen  of pure  diphtheria  toxin  per  Lf unit.  Moreover,  the  method 
was found independent  of the purity of the  toxin and antitoxin preparations 
employed.  Rane  and  Wyman  (10)  have  described  a  flocculation  reaction 
between scarlet fever toxin and antitoxin which they regard as a specific anti- 
gen-antibody reaction because  of the  close in  vivo-in  vitro  correlation  which 
they obtained using a great many preparations of toxin and antitoxin.  If this 
flocculation reaction is  indeed specific, then it should be possible to estimate 
the nitrogen per focculating unit of pure scarlet fever toxin from a quantitative 
study of its reaction with antitoxin, providing that the reaction is analogous 
to  the  diphtheria  system.  Unfortunately,  Evans  and  Gottschall  (11)  and 
Bunney and Koerber (12) have failed to obtain satisfactory correlation between 
the flocculation reaction and in vivo titrations of scarlet fever toxin, and the 
latter  workers  have  expressed  some  doubt  regarding  the  specificity  of  the 
reaction.  It  is  hardly  necessary  to  point  out  that  before  the  flocculation 
reaction can be used to estimate the activity of pure scarlet fever toxin,  its 
specificity must be established beyond reasonable doubt.  With these factors 
in mind we have undertaken a  quantitative study of the flocculation reaction 
of Rane and Wyman (10)  between scarlet fever toxin and antitoxin. 
EXPERIMENTAL 
Cultures.--Toxins were prepared using two different scarlatinal strains of hemolytic 
streptococcus.  Strain NY No.  5 has been most commonly used commercially for 
the production of scarlet fever toxin.  It has been shown by Pane and Wyman (13) 
that strain No. 594 produces several times as much toxin as NY No. 5.  Evidence 
that the toxin produced by No. 594 is identical with that of NY No. 5 has been given 
by Rane and Wyman, and by Plummer and Fraser (14).  We are indebted to Dr. Leo 
Rane of the Antitoxin and Vaccine  Laboratory, Jamaica Plain, Massachusetts, for 
cultures of the two strains. 
Preparation  of Toxin.--60  liters of culture of strain No. 594 and 30 liters of NY 
No. 5 were grown in 5 gal. pyrex carboys on the casein hydrolysate medium described 
elsewhere  (15).  After 60 hours growth at 35°C. with neutralization and continuous 
stirring the cultures were centrifuged and the supernate sterilized  by Seitz filtration. 
The average yield of erythrogenic toxin from No. 594 was 9 Lf/cc. (ca. 300,000 S.T.D. 
per cc.), and from NY No. 5 was 2 Lf/cc. (ca. 60,000 S.T.D. per cc.). 
Concentration  and Partial Purification  of Toxin.--The  toxic filtrates from the two 
strains were concentrated and purified separately by the same procedure as follows: 
The culture filtrate was concentrated in vacuo at 30-35°C.  to about 1/7 its original 
volume.  The active material was then precipitated by adding 500 gin. of ammonium 
sulfate for each liter of concentrate and enough ammonia to keep the solution between 
pH 6.5  and  7.0.  On standing overnight at room temperature, the toxin formed a 
dark flocculent  layer near the surface.  A large amount of crystalline sediment also 
appeared.  The precipitates were filtered by suction and dissolved by dialysis against 
running water.  Mter thorough dialysis the solution  remained turbid and contained 
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The volume at  this  point was 2  to 5 per cent  that  of the  original culture filtrate. 
Ammonium sulfate was added to four-tenths saturation and a small amount of dark 
brown inactive precipitate was removed by filtration.  This filtrate was brought to 
0.75 saturation with ammonium sulfate and the toxin precipitated.  The dark brown 
precipitate  containing the toxin was separated  by filtration  through paper and dis- 
solved in a  small  volume of water.  The solution was dialysed against  changes of 
distilled water and finally against Setrenson's  phosphate buffer at pH 6.8 containing 
1:5000 merthiolate.  The flocculation reaction was used at  each step to follow the 
fractionation of the toxin.  No attempt was made to effect further purification. 
Properties  of Partially  Purified  Toxin.--From  60 liters  of No.  594  culture 
filtrate,  400 cc. of purified toxin containing 950 Lf/cc., 3  )<  107 S.T.D./cc., and 
0.895 mg. nitrogen per cc. were obtained at this point, representing an overall 
yield of about  70 per cent.  From 30 liters  of NY 5, 33  cc. of purified  toxin 
TABLE I 
Some Properties of Partially  Purified Scarlet Fever Toxin 
Nitrogen content (per cent) .................... 
Activity (skin test doses per mg.) 
Rabbit .................................... 
Human .................................... 
Mg. nitrogen per Lf unit ...................... 
Flocculation time for 38 Lf per cc. at 48°C. using 
antitoxin 531B (min.) ..................... 
Per cent precipitable* ......................... 
Strain No. 594  Strain NY 5 
14.0  12.5 
8,000,000 
8,000,000 
0.00054 
30 
43 
12,000,000 
12,000,000 
0.00035 
30 
66 
* Calculated using 0.00023 mg. nitrogen per Lf unit of toxin and based on the total nitrogen 
in the toxin. 
were obtained, containing 800 Lf/cc., 2 X  107 S.T.D./CC., and 0.345 mg. nitrogen 
per cc., a yield of about 45 per cent.  Both preparations gave strongly positive 
biuret, Millon and xanthroproteic tests in 0.3 per cent solution.  Both prepara- 
tions  contained  some  material  which  was  coagulated  by  heating  to  100°C. 
Dilutions  of  the  594  toxin  were  injected  intravenously  into  a  few  rabbits. 
These must be regarded as only preliminary experiments  but have indicated 
that the ~.L.D. for 2 to 3 kilo Chinchilla rabbits is about 50 Lf (1,500,000 S.T.D.) 
by the intravenous route.  One rabbit given 95 Lf and 300 units of antitoxin 
survived.  Rane  and  Wyman  (13)  report  180 Lf lethal  for  5  lb.  Chinchilla 
rabbits when injected subcutaneously.  Some properties of the partially puri- 
fied toxin after further dialysis are summarized in Table I. 
In agreement with other workers (Kodama (16), Hooker and Follensby (17), 
and Barron et  al.  (7))  we have found the toxin to be relatively resistant  to 
the action of the proteolytic enzymes, pepsin, papain,  and trypsin.  The floc- 
culating power of the toxin was not impaired by treatment with these enzymes. 548  SCARLET  FEVER TOXIN-ANTITOXIN  FLOCCULATION REACTION 
That these toxin solutions contained other streptococcal proteins was shown 
by a  positive ring test when a  1/100 dilution of the concentrated toxin was 
added to an immune rabbit serum prepared against a smooth strain of hemolytic 
streptococcus. 
Antitoxins.~--Antitoxin  No.  2101 (Squibb Laboratories) was whole horse serum. 
Antitoxin No.  24739,  also  obtained from  Squibb Laboratories,  was  a  commercial 
preparation of pseudoglobulin.  Antitoxins No.  531A and 531B,  obtained from the 
National Drug Company, were from different bleedings from the same horse.  They 
were solutions of the water-soluble globulin precipitated between 0.3 and 0.5 satura- 
tion with ammonium sulfate.  Antitoxin No. 47E  (National Drug Company) was a 
sample of  enzyme-digested antitoxic pseudoglobulin.  Antitoxin No.  Sll3A was  a 
pseudoglobulin preparation received  from  the  Antitoxin and Vaccine Laboratory, 
Jamaica Plain, Massachusetts.  The flocculation  times of the various antitoxins  varied 
between 25 and 130 minutes at 48°C. with 38 Lf units of toxin (See Table III). 
The Ftocculation  Reaction.--The  flocculation tests Were done in the usual manner 
at 48°C.  with a  constant amount of toxin and increasing amounts of antitoxin.  In 
evaluating flocculation titers or Lf units per cc. we have used the arbitrary standard 
set up by Rane and Wyman (10).  In the quantitative studies, the amount of anti- 
toxin in each tube was kept constant at 600 units.  Increasing amounts of toxin were 
added and the volume in each tube was adjusted to 5 cc. with saline.  These mixtures 
were set in a water bath at 38°C.  for 3 hours and overnight in the cold.  The tubes 
were then centrifuged, the supernates drawn off for test, and the precipitates broken 
up and washed  three  times with chilled saline.  Nitrogen in the  precipitates was 
determined by the micro-Kjeldahl method.  The supernates were  tested for excess 
toxin by skin tests in rabbits.  All tests were carried out in duplicate. 
Skin  Tests.--The  skin reactivity of  toxin solutions and the supernates from the 
flocculation tests was determined by injecting graded dilutions into the skin of white 
or grey Chinchilla rabbits.  The dilutions were made in saline in such a manner that 
each successive  tube in a series  contained half as much toxin as the preceding tube. 
The  reactions after  24  hours  and 40  hours were  compared with  similar reactions 
produced in the same rabbits by the Standard National Institute of Health toxin.  3 
Three rabbits were used for each series of titrations and the results averaged.  In the 
discussion of  our results we  have regarded the  skin test values as  significant only 
within 4-50 per cent. 
The skin reactivity of the concentrated and purified toxin preparations was con- 
firmed exactly by tests carried out on susceptible human subjects using the Standard 
National Institute of Health toxin for comparison.  We are greatly indebted to Dr. 
George F. Leonard of the Biological Laboratories, E. R. Squibb and Sons, for carrying 
out the human skin tests. 
2 We are greatly indebted to Dr. W. E. Bunney of the Squibb Laboratories, New 
Brunswick, New Jersey, to Mr. A. M.  Slee of the National Drug Company, Swift- 
water, Pennsylvania,  and to Dr. E. S. Robinson of the Antitoxin  and Vaccine Labora- 
tory, Jamaica Plain, Massachusetts, for the antitoxins used in this work. 
3 This toxin was supplied by Dr. M. V. Veldee of the National Institute of Health. 
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TABLE II 
Quantitative Flocculation of A ntitoxic  Pseudoglobulin 531 
Increasing amounts of scarlet fever toxin added to 600 units of antitoxin 
I 
Toxin 
added 
M 
300 
340 
350 
400 
440¶ 
450¶ 
500 
540 
600 
640 
700 
740¶ 
80O¶ 
840 
900 
940 
1000 
600 
600 
II 
Toxin  * 
aitrogen 
III 
N!trogen 
In pre- 
cipitate 
mg.  ~g. 
O. 069  O. 174 
0.078  0.400 
0.081  0.502 
0.092  0.61611 
O. 100  O. 625 
O. 103  O. 655 
0.115  0.675 
0.124  0.680 
0.138  0.700 
0.147  0.705 
0.161  0.719 
0.164  0.715 
0.184  0.710 
0.193  O. 666 
0.207  0.513 
0.216  0.162 
0.230  0.224 
0.138 
0.138 
F 
1.340 
1.360 
IV  RVio~  VI 
Antitoxin 
nitrogen in  A-nitrogen  / Total skin test 
precipitate  T-nitrogen doses  added 
IlI-II  IV + II 
0.560 
0.556 
0.562 
0.558 
0.558 
anti-Ea** 
Ea-anti-Ea 
Ea-anti-Ea 
~.1 
3A 
3..  ~ 
D 
9,000,000 
10,000,000 
10,500,000 
12,000,000 
13,000,000 
13,500,000 
15,000,000 
16,000,000 
18,000,000 
19,000,000 
21,000,000 
22,000,000 
24,000,000 
25,00O,000 
27,000,000 
28,000,000 
30,000,000 
18,000,000 
18,000,000 
VII 
Total skin test 
doses§ in 
supernate 
5,000,000 
2,000,000 
1,000,000 
550,000 
150,000 
150,000 
100,000 
100,000 
3,000,000 
15,000,000 
7,5oo,ooott 
5,ooo,ooott 
none 
VIII 
Strain 
No. 
594 
NY5 
594 
594 
NY5 
594 
594 
NY5 
594 
NY5 
594 
NY5 
594 
NY5 
594 
NY5 
594 
594 
594 
594 
* The nitrogen precipitated by 500  Lf units of toxin (column III) subtracted from that 
precipitated by 700 Lf and divided by 200 gives 0.00022  mg. nitrogen per Lf unit of toxin. 
The figure used in column II, however, is 0.00023  mg. of nitrogen per Lf unit, the average 
obtained from three titrations including the above. 
t All values except the one marked [[ are the averages of duplicate determinations. 
Values are calculated only for points of complete precipitation in the equivalence zone. 
§ These values were determined in the skin of rabbits.  They represent averages of tests 
on three rabbits. 
¶ Incomplete  flocculation. 
** Ea  =  egg albumin. 
tt These  two  values are  undoubtedly  low.  They  are  included  because  they were  de- 
termined on the same rabbits and show that there is no significant amount of toxin adsorbed 
to the egg albumin-anti-egg albumin precipitate. 
RESULTS 
The  results  of  titrations  of  antitoxin  531  with  both  NY5  and  594  scarlet 
fever toxins are given in detail in Table II and plotted in Fig.  1.  A  quantita- 
tive diphtheria toxin-antitoxin titration is also plotted in Fig. 1 for comparison. 550  SCARLET  FEVER  TOXIN-ANTITOXIN  FLOCCULATION  REACTION 
The reaction between scarlatinal toxin and antitoxin resembles the quantitative 
diphtheria  toxin-antitoxin reaction in  several  respects.  Thus,  for example, 
precipitation occurs within a  narrow zone only.  Moreover, the Danysz phe- 
nomenon  is  readily demonstrable  by flocculation in  the  inhibition  zone  of 
antitoxin excess and although not indicated in Table TI, its magnitude is the 
same as with the diphtheria system.  Thus after 200 Lf of scarlet fever toxin 
were incubated with 600 units of antitoxin, no flocculation occurred.  However, 
6 
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^ 
SCARLET FEVER ]OXIN  AD]~D  (L£  units)* 
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FIG.  1.  Quantitative toxin-antitoxin flocculation  reaction.  Curve A,  diphtheria 
system, Pappenheimer and Robinson (9).  Curve B, scarlet fever system.  Q  =  594 
toxin,  x  =  NY5 toxin. 
when the mixture was then treated with increasing amounts of toxin, only 200 
units of antitoxin were found by flocculation rather than 400 units expected if 
there  were  no  Danysz  phenomenon.  In  spite  of  these  similarities,  certain 
important  quantitative  differences exist between  the  diphtheria  and  scarlet 
fever toxin-antitoxin reactions.  Although the width of the flocculation zone 
is almost exactly the  same for both reactions, the region of nearly complete 
precipitation is more than  twice as broad for the diphtheria  toxin-antitoxin 
system as for the scarlet fever toxin-antitoxin system.  This is not only true 
for antitoxin No. 531 shown in Fig. 1, but holds for all the scarlet fever anti- 
toxins  which  we  have  studied.  In  fact  antitoxin  No.  531  was  chosen  for GEORGE  A. HOTTLE  AND  A. M. PAPPENI[EIMER~  JR.  551 
detailed study because its zone of nearly complete precipitation was the broad- 
est of all the scarlet fever antitoxins we have examined. 
Several quantitative titrations with various antitoxin preparations are sum- 
marized in Table III. 
2101 
531A 
531B 
Sll3A 
24739 
47E 
II 
Unit 
Antoxin  antito  per cc. 
No.  floccu 
tioz 
132 
31~ 
25( 
94( 
88( 
72( 
dn 
by 
a- 
Results 
III 
Floccul~- 
tion time 
(38 Lf/cc. 
at 48°C.) 
25 
35 
30 
130 
110 
46 
TABLE  III 
"tom  Various  Toxin-Antitoxin  Titrations 
IV 
Toxin 
strain 
No. 
594 
594 
NY5 
594 
594 
594 
V 
Toxin nitrogen 
per Lf 
(0.00036)t 
0.00022 
0.00021 
0.00024 
VI 
Maximum 
specifically* 
precipitable 
antitoxin 
nitrogen from 
600 units 
antitoxin 
rag. 
0.581 
0.560 
0.552 
0.612 
0.484 
0.458 
Vll 
Total 
nitrogen 
specifically 
precipitated 
per cent 
1.0 
1.9 
2.0 
3.9 
2.4 
1.9 
VIII 
Ratio 
A-nitrogen 
T-nitrogen 
at flocculation 
point 
4.2 
4.1 
4.0 
4.4 
3.5 
3.3 
* Calculated using 0.00023  mg. nitrogen per Lf unit of toxin. 
t  The results of this titration were irregularly high, indicating that the precipitates were 
not washed sufficiently. 
:~ The equivalence zone was too narrow to calculate a value. 
DISCUSSION 
In  the  previous study  of the  diphtheria  flocculation reaction  (9),  it  was 
assumed  that  throughout  the equivalence zone precipitation was  essentially 
complete, and that even if the specific toxin-antitoxin complex were slightly 
soluble within the zone, no appreciable dissociation occurred, since no toxin 
could be detected in the supernate by the sensitive rabbit intracutaneous test. 
This is not true in the present instance.  Even at the flocculation point the 
scarlet  fever  toxin-antitoxin  complex  is  somewhat  soluble  and  the  soluble 
complex is apparently dissociated to an appreciable extent.  Since it is prac- 
tically completely dissociated at high dilutions,  the skin test method may be 
used to determine roughly its solubility.  Column III of Table IV shows that 
the solubility of the toxin-antitoxin complex at the flocculation point remains 
practically  constant  over a  50-fold  range  of  concentration.  The  solubility 
at ice box temperature corresponds to about 1 Lf per cc. (30,000 S.T.D. per co.). 
It  is  well  established  that  antigen-antibody  reactions  are  reversible  and 
that  under certain conditions the antigen-antibody complex may dissociate. 
Glenny, Pope, and Waddington  (18)  have presented evidence that the  diph- 
theria toxin-antitoxin complex may dissociate to an appreciable extent upon 
dilution, particularly when antitoxins of low "avidity" are used.  When dilute 552  SCARLET  FEVER  TOXIN-ANTITOXIN FLOCCULATIO1W REACTION 
solutions of diphtheria toxin are neutralized in vivo, relatively more antitoxin 
of low "avidity" is necessary for complete neutralization  than  would be pre- 
dicted from in vitro  tests  carried out using more concentrated  solutions.  In 
our  opinion  the  dissociation  of  the  toxin-antitoxin  complex  upon  dilution 
provides a reasonable explanation for the large discrepancy between the in vitro 
and in vivo neutralization of scarlet fever toxin by antitoxin noted by Rane and 
Wyman (10).  Rane and Wyman found 60,000  S.T.D. neutralized per unit of 
antitoxin in the flocculation test rather than the expected in vivo neutralization 
of only 50 S.T.D.  In the latter case toxin and antitoxin are present in fairly 
high  dilution.  If  the  dissociation  constants  are  large,  it  follows  from  the 
TABLE IV 
Skin  Tests  on  Supernates from  Floccules at  the  Flocculation Point 
I 
Toxin and antitoxin 
concentration at 
flocculationpoint 
units  per co. 
10 
40 
60 
120 
180 
475 
II 
Skin test doses per cc. 
of mixture 
300,000 
1,200,000 
1,800,000 
3,600,000 
5,400,000 
13,000,000 
III 
Skin test doses* found 
in supernate per  cc. 
30,000 
30,000 
20,000 
40,000 
40,000 
80,000 
IV 
Total toxin-antitoxin 
complex found in super- 
nate at flocculation  point 
per tens 
10.0 
3.0 
1.0 
1.0 
0.7 
0.6 
All mixtures were set at 38°C. for 3 hrs., then at 6°C. for 18 hrs. 
* These values  were determined in the skin of rabbits.  They represent averages of tests on 
three rabbits. 
A curious observation was made during these tests.  Although  the reactions after 24 hours 
were similar, after 4 clays those from the supernates with 180 units or less per cc. had faded, 
but those from the 475 unit supernate persisted with increased intensity.  There was no 
increase in size. 
mass law  that an excess of antitoxin must be used if neutralization is  to be 
complete.  In the flocculation reaction last  traces of toxin need not be neu- 
tralized.  We have found 30,000  S.T.D. neutralized  by one unit of antitoxin 
in the flocculation test but do not regard this difference from 60,000 as par- 
ticularly significant in view of the difficulties of skin testing in rabbits. 
As we have already pointed out in the introduction, before the flocculation 
reaction can be used for predicting the potency of pure scarlet fever toxin and 
antitoxin,  it is necessary to prove that the reaction is a  specific  one between 
the  toxin itself  and  antitoxin.  From an  examination of Table II it will be 
noted that within the region of maximal precipitation (i.e. S00 to 740 Lf toxin 
with 600 units of antitoxin) less than 1 per cent of the toxin was found in the 
supernatant by intracutaneous rabbit test.  Outside the equivalence zone, no GEORGE  A. HOTTLE  AND  A. ~[. PAPPENHEIM[ER,  JR.  553 
apparent  neutralization  occurs when  tested  by  the  intracutaneous  method, 
presumably because  of dissociation.  That  the precipitation of the  toxin  is 
not due to non-specific absorption by the precipitate is indicated by the fact 
that even twice as much specific egg albumin-anti-egg albumin horse antibody 
precipitate formed in the presence of scarlet fever toxin, failed to carry down 
the toxin (Table II).  We feel that these demonstrations of the specific pre- 
cipitation of scarlet fever toxin by antitoxin in the equivalence zone are con- 
clusive evidence that the reaction we are dealing with is in fact specific. 
Evans  and  Gottschall  (11)  and  Bunney and  Koerber  (12)  have recently 
reported failure to obtain adequate correlation between the flocculation titer 
and the in vivo potency of scarlet fever toxins.  It seems worth while to discuss 
possible reasons for the discrepancy in view of the conclusion drawn above. 
The fact that the present reaction is specific is not proof of its usefulness as a 
general method of assay, and does not mean that other flocculating antibodies 
do not occur in antitoxins made by immunizing with scarlet fever toxins pro- 
duced on infusion and peptone media.  Rane and Wyman (10) note that oc- 
casional serums showed double zones with certain toxins, of which only one 
zone appeared to be specific.  Bunney and Koerber (12) found that concen- 
trates  of infusion broth  or peptone gave flocculation reactions with certain 
scarlet fever antitoxins.  We have confirmed the observation of Bunney and 
Koerber that flocculation may occur with peptone and antitoxic horse serum. 
However,  after  removal  of  the  non-specific  antibody  by  flocculation  with 
concentrated  peptone  solution,  the  antitoxin  still  focculated  to  titer  with 
scarlet fever toxin.  Bunney and Koerber also reported that they were unable 
to flocculate toxin produced on a  casein hydrolysate medium.  Using a  par- 
ticularly rapidly flocculating antitoxin we were able to flocculate some of this 
casein hydrolysate toxin kindly sent us by Dr. Bunney and Dr. Koerber.  The 
toxin which they sent us contained 200,000 S.T.D. per cc. and flocculated slowly 
at 7 Lf per cc. 
While the non-specific reactions discussed above may account for some of 
the failures to obtain satisfactory in vivo-in  vitro correlation, it seems unlikely 
that this can be the whole explanation of Evans and Gottschall's results since 
they tested their toxins over a wide range and report only one zone of floccula- 
tion.  There is another possible explanation for the observed discrepancies in 
titrating scarlet fever toxins.  Hooker and Follensby (17) have demonstrated 
that certain scarlet fever strains of streptococcus, including the NY5  strain, 
may under  certain  conditions,  produce  two  erythrogenic toxins,  A  and  B. 
The B toxin is more labile than and immunologically distinct from the ordinary 
Dick toxin.  The presence of two immunologically dissimilar skin toxins would, 
of course, interfere with their assay by the flocculation test.  In our own ex- 
perience, we have encountered no  di~culty in  following the purification of 
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Presumably, under our conditions for growing the organisms, no appreciable 
amount of the Toxin B of Hooker and Follensby was produced. 
The studies of Rane and Wyman (13) and Plummer and Fraser (14) have 
suggested that  the toxin produced by strain  No. 594  is identical in its im- 
munological behavior to NY5  toxin.  The former has not been accepted as 
yet by the Scarlet Fever Committee.  Table II and Fig. 1 show that the No. 
594 and NY5  toxins are quantitatively identical in the flocculation reaction 
within the limits of experimental error.  Because the No. 594 strain produces 
several times as much toxin as the NY5 strain  under  similar  conditions,  the 
former strain should prove useful for toxin production. 
Since skin tests on the supernatants from the equivalence zone show that 
at least 99 per cent of the toxin-antitoxin complex is precipitated from 600 
units of antitoxin by 500 to 740 Lf of toxin, it is possible to calculate the nitro- 
gen per Lf unit for pure scarlet fever toxin from the slope of the quantitative 
flocculation curve within this region.  From three titrations on two different 
antitoxins,  careful nitrogen determinations indicated that pure scarlet fever 
toxin contains 0.00023 rag. nitrogen per Lf unit, a value which we believe to be 
accurate to within at least 20 per cent.  This nitrogen per Lf unit does not 
have the same significance as in the case of diphtheria toxin because there is 
no standard flocculating antitoxin available for comparison.  It may also be 
calculated from the data in Tables II and III that pure scarlet fever toxin 
contains very close to 1.3 X  108 skin test doses per rag. of nitrogen.  Similar 
calculations indicate  that  pure scarlet fever antitoxin contains 0.00093  mg. 
nitrogen per unit.  Since the concentrated and partially purified No. 594 toxin 
contained 0.00054 mg. nitrogen per unit and 5.7 X  l0  T  S.T.D. per mg. nitrogen, 
we estimate that the preparation contains about 43 per cent scarlet fever toxin 
assuming that the toxin has the same nitrogen content as protein.  Similarly, 
the NY5 preparation contains about 66 per cent scarlet fever toxin. 
From Table III  it will be noted that with  two exceptions the maximum 
antitoxin nitrogen precipitated by toxin from 600 units  of antitoxin varied 
between 0.552  and  0.612  mg.  The two exceptions are  antitoxins  No.  47E 
and  No.  24739.  Antitoxin  No.  47E  (National  Drug  Company)  had  been 
treated with pepsin according to the procedure of Pope (19) and from its low 
precipitable nitrogen it may be assumed that a  splitting of the molecule has 
occurred analogous to pepsin-treated diphtheria antitoxin (9, 20).  Antitoxin 
No. 24739  (Squibb Laboratories) was a concentrated pseudoglobulin prepara- 
tion which had not been subjected to the action of pepsin.  We are unable to 
explain its low specifically precipitable nitrogen content at this time. 
According  to  the  above  calculations,  most  of the  preparations  of scarlet 
fever toxin which have been reported in the literature were of a very low order 
of purity.  We feel that detailed chemical studies on such preparations should 
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Lyman (7) should be interpreted with caution, since according to our calcula- 
tions,  their preparation  contained only about 0.2 per cent actual toxin.  On 
the other hand, it seems likely that the preparations of Stock (6) which con- 
tained 108 S.T.D. per nag. of nitrogen, were of a very high degree of purity.  In 
agreement with Stock (6) and Barron, Dick, and Lyman (7) our results suggest 
that scarlet fever toxin is a protein.  Our preparations, estimated to be about 
45 per cent and 66 per cent pure, contained 14 per cent and 12.5 per cent nitro- 
gen respectively and gave strongly positive protein  tests  in dilute solution. 
We also feel that the striking qualitative resemblance of the scarlet fever toxin- 
antitoxin reaction  to  other protein-antiprotein ttocculation reactions,  in the 
horse,  namely diphtheria  toxin-antitoxin (9),  egg albumin-anti-egg albumin 
(21),  and  hemocyanin-antihemocyanin (22),  constitutes  strong  supporting 
evidence for the conclusion that scarlet fever toxin is a protein.  In agreement 
with other workers we have found scarlet fever toxin to be a protein of unusual 
resistance to action of the proteolytic enzymes pepsin,  trypsin, and papain. 
The ratio of antitoxin nitrogen to toxin  nitrogen at the flocculation point 
is 4.1:1  for the scarlet fever  system (Tables II and III).  This is somewhat 
higher than the corresponding ratio of 3.6:1  found for the diphtheria  toxin- 
antitoxin complex, and in our opinion suggests that the nitrogen content of 
scarlet fever toxin is lower than that of diphtheria toxin.  Both Stock's purest 
preparations  (6)  and our own contain only 11  to  14 per  cent nitrogen.  It 
therefore appears likely that the composition of the floccules at the flocculation 
point is almost exactly the same for the two systems.  The molecular composi- 
tion at the flocculation point for the diphtheria  toxin-antitoxin and egg al- 
bumin-anti-egg  albumin  (horse)  systems  corresponds  respectively  to  TA~. 
and EaA2  (21).  If now we assume that scarlet fever antitoxin has the same 
molecular weight  as  diphtheria  antitoxin  (180,000)  and  that  the  molecular 
composition of the specific precipitate with toxin is the same for the two sys- 
tems, then it may be predicted that the molecular weight of scarlet fever toxin 
will be found to be about the same as that of diphtheria toxin, i.e. about 70,000 
(20,  23). 
SUM-MARY 
1.  Highly purified scarlet fever toxin has been prepared from culture filtrates 
of two scarlatinal strains (NY5 and 594B)  of hemolytic streptococcus grown 
on a  medium of defined composition. 
2.  The flocculation reaction of Rane and Wyman has been studied quanti- 
tatively and has been shown specific for scarlet fever toxin and antitoxin. 
3.  Scarlet fever toxin from strains NY5 and 594B are quantitatively identical 
in their immunological behavior. 
4.  Pure scarlet fever toxin contains 0.00023  rag.  nitrogen per  flocculating 
unit and close to 1.3 X  108 skin test doses per mg. nitrogen as calculated from ~56  SCARLET  FEVER  TOXIN-ANTITOXIN  FLOCCULATION  REACTION 
the  immunological data.  Both  the  immunological and  the  analytical  data 
suggest  that  scarlet  fever toxin  is  a  protein.  Similar  calculations  indicate 
that scarlet fever antitoxin contains 0.00093 rag. nitrogen per unit. 
5.  The scarlet fever toxin-antitoxin complex is readily dissociated in dilute 
solutions.  In  this respect the scarlet fever toxin-antitoxin system contrasts 
sharply with  the  diphtheria toxin-antitoxin system. 
6.  The scarlet fever toxin-antitoxin reaction is discussed in relation to other 
flocculation reactions. 
Since this paper went to press  further evidence for the specificity  of the  scarlet 
fever toxin-antitoxin flocculation reaction has appeared.  H. Proom (J.  Path.  and 
Bact., 1941, 53, 39) has succeeded in recovering scarlet fever toxin in 5 to 10 per cent 
yield from washed toxin-antitoxin floccules by tryptic digestion. 
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